1. Technological Advancements in Monoclonal Antibodies
   José F. Santos-Neto et al, 2021, The Scientific World Journal CrossRef
2. Antibody drug conjugates: hitting the mark in pancreatic cancer?
   Nicole L. Wittwer et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
3. Antibody-drug conjugates: beyond current approvals and potential future strategies
   Siddharth Menon et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef
4. Generation and Characterization of SORT1-Targeted Antibody–Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor
   Weiliang Zhuang et al, 2023, International Journal of Molecular Sciences CrossRef
5. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
   Gustavo A. Arias-Pinilla et al, 2021, Cancers CrossRef
6. Tissue factor-induced fibrinogenesis mediates cancer cell clustering and multiclonal peritoneal metastasis
   Makoto Miyazaki et al, 2023, Cancer Letters CrossRef
7. Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate
   Hiroki Takashima et al, 2021, Cancer Science CrossRef
8. Advancing Tissue Factor-targeted Therapy for Osteosarcoma via Understanding its Role in the Tumor Microenvironment
   Jiro Ichikawa et al, 2023, Current Pharmaceutical Design CrossRef